Lymphoma - Non B cell neoplasms

Home Chapter Home Jobs Conferences Fellowships Books

Lymphoma - Non B cell neoplasms

Post-transplantation lymphoproliferative disorders (PTLD)

Polymorphic PTLD

Reviewer: Dragos Luca, M.D. (see Reviewers page)
Revised: 26 October 2011, last major update September 2011
Copyright: (c) 2001-2011, PathologyOutlines.com, Inc.

Definition
=========================================================================

● Morphologically polymorphic lesions composed of immunoblasts, plasma cells and small and intermediate-sized lymphoid cells that efface the architecture of lymph nodes or form destructive extranodal masses, and that do not fulfil the criteria for any of the recognized types of lymphoma described in immunocompetent hosts (WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edition, Lyon 2008)
● P-PTLD: polymorphic versus M-PTLD: monomorphic

Clinical features
=========================================================================

● Variable frequency: 20-80% of all PTLD
● Most common pediatric PTLD
● May regress after reduction in immunosuppression, or may progress to lymphoma

Micro description
=========================================================================

● Architectural effacement but full range of B cell maturation from immunoblasts to plasma cells and variable-sized lymphocytes
● May have geographic necrosis, HRS-like cells, numerous mitoses
● Some may have monomorphic-appearing areas – may suggest a continuous spectrum between P- and M-PTLD
● May have bone marrow lymphoid aggregates of unknown significance (P-PTLD > M-PTLD; children > adults), not always EBV-positive

Micro images
=========================================================================

Various images

Immunophenotype
=========================================================================

● B cells with (~50%, also by flow cytometry) or without light chain restriction and heterogeneous T cells
● Light chain restriction may be focal or different clonal populations may be present simultaneously
● RS-like cells (when present): CD30+, CD20+, but CD15-
● EBV (EBER) positive
● Ki-67 may be high

Genetics and molecular
=========================================================================

● Clonally rearranged Ig genes but clones less prominent than M-PTLD
● EBV terminal repeat analysis – most sensitive method for clonal populations in EBV+ cases
● Tumors at different sites may be clonally distinct
● 75% of P-PTLD have Ig Variable mutations; no significant T cell clones
● CGH: some recurrent abnormalities also seen in M-PTLD
● May have BCL6 somatic hypermutations

End of Lymphoma - Non B cell neoplasms > Post-transplantation lymphoproliferative disorders > Polymorphic PTLD

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).